ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163949 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163949; 2) Community: the network communities that were significantly associated with the response to NSC 163949; 3) Molecule: the relationships between components within communities and NSC 163949; 4) MDR: the compounds that were significantly associated with the NSC 163949.

NSC Compound Enrichment Correlation
NSC 144153 Datiscoside 0.021946808377072 -0.10254465
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.0219468083770723 -0.029051157
NSC 19441 FDA 0283 0.0219468083770723 0.24699609
NSC 268665 Null 0.0219468083770723 0.19036776
NSC 298223 Antibiotic CC 1065 (9CI) 0.0219468083770723 0.27241231
NSC 343378 1H-Indene-1,3(2H)-dione, 2-[[(2-methylphenyl)imino]phenylmethyl]- 0.0219468083770723 -0.095936453
NSC 59620 (4a,6a,9-trimethyl-6,7-dioxo-2,3,4,4b,5,6b,10,10a,11,11a,11b,12,13,13a-tetradecahydro-1H-indeno[2,1-a]phenanthren-2-yl) acetate 0.0219468083770723 -0.025582333
NSC 606869 Clofarabine 0.0219468083770723 0.12525786
NSC 642407 Null 0.0219468083770723 -0.12520845
NSC 645305 Null 0.0219468083770723 0.42165368
Total:73  Current:33    [First] [Prev] [Next] [Last]